CI
ROIV icon

CX Institutional’s Roivant Sciences ROIV Stock Holding History

CX Institutional’s Portfolio ROIV Stock Details ROIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$23K Buy
629
+1
+0.2% +$36 ﹤0.01% 1203
2026
Q2 		$22K Buy
628
+2
+0.3% +$59 ﹤0.01% 1158
2026
Q1 		$17K Buy
+626
New +$16.1K ﹤0.01% 1165

Other funds holding ROIV

TSC
Two Seas Capital Rye, New York $8.68B AUM 78.08% 1-Year Est. Return
FFAS
FIG Financial Advisory Services Oklahoma City, Oklahoma $165M AUM 16.79% 1-Year Est. Return
LWA
Ledgewood Wealth Advisors Exeter, New Hampshire $181M AUM 9.93% 1-Year Est. Return
EFG
Everhart Financial Group Dublin, Ohio $1.62B AUM 25.73% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
WPC
Wedmont Private Capital West Chester, Pennsylvania $4.18B AUM 18.65% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
DLA
Douglas Lane & Associates New York $7.46B AUM 24.36% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return
AIM
Acropolis Investment Management St. Louis, Missouri $2.49B AUM 10.8% 1-Year Est. Return

CX Institutional's ROIV Position: Q3 2026 in Review

CX Institutional increased its Roivant Sciences (ROIV) stake by 0.16% in Q3 2026, buying an estimated $36 and bringing the position to 629 shares worth $23K. The position accounts for ﹤0.01% of the portfolio, ranked #1203.

CX Institutional first reported a position in ROIV in Q1 2026 and has held it in 3 quarters since. 20 funds tracked by Wall St. Rank hold ROIV as of Q3 2026.

  • CX Institutional held 629 shares of Roivant Sciences worth $23K as of Q3 2026.
  • CX Institutional bought 1 Roivant Sciences share in Q3 2026, an estimated $36.
  • Roivant Sciences made up ﹤0.01% of CX Institutional's portfolio in Q3 2026, its #1203 holding.
  • CX Institutional first reported a position in Roivant Sciences in Q1 2026 and has held it in 3 quarters since.
  • 20 funds tracked by Wall St. Rank held Roivant Sciences as of Q3 2026.

Based on CX Institutional's 13F filing for Q3 2026, filed 2 Oct 2026.